The shares of Sudeep Pharma listed on the NSE and BSE today, debuting at a premium of 24% on Dalal Street. The price band of the issue is set between Rs 563-593 per share.
| Sudeep Pharma IPO | Key Details |
| Price band | Rs 563-593 per share |
| Subscription | 93.71 times |
| GMP | 20.40% |
| IPO Allotment date | November 26 |
| Listing date | November 28 |
Sudeep Pharma IPO: Key details
Sudeep Pharma raised Rs 895 crores via a mix of fresh issue and an offer for sale. The IPO consisted of 0.16 crore fresh shares of Rs 95 crores and an offer for sale of 1.35 crore shares worth Rs 800 crores. The IPO was opened for bidding on November 21 and ended on November 25. The allotment was finalised on November 26.
Sudeep Pharma IPO: Book manager and registrar
ICICI Securities worked as the book-running lead manager for the IPO, and MUFG Intime India was the registrar of the issue.
About Sudeep Pharma
Sudeep Pharma, established in 1989, is a technology-led manufacturer of excipients and speciality ingredients serving the pharmaceutical, food, and nutrition industries. It has a global footprint spanning from the U.S. to South America to Europe, the Middle East, Africa, and Asia-Pacific. The company operates three manufacturing facilities in Vadodara, Gujarat, and, following its acquisition of NSS( Nutrition Supplies and Services) in 2025, an additional facility in Ireland.
Sudeep Pharma Share Price, IPO Listing Highlights: Check Coverage on Sudeep Pharma IPO Listing, GMP, Share Price, Price Band, Review
Sudeep Pharma Share Price, IPO Listing, GMP Live: Where the company manufactures
Sudeep Pharma operates three manufacturing plants in Gujarat. Together, these plants have an annual capacity of 72,246 metric tonnes. At present, the company uses a little over half of this capacity. It is also building a new facility in Gujarat with ongoing capital spending.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Products the company makes
Its product line includes items such as zinc gluconate, magnesium phosphate, simethicone, stearic acid, chromium chloride, and aluminium hydroxide gel. These ingredients are used in making tablets, capsules, syrups, fortified foods, and infant nutrition items. The products follow global quality standards including United States Pharmacopeia, British Pharmacopeia, European Pharmacopeia, and Food Chemicals Codex.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Main areas of business
The company works across three key segments: pharmaceutical excipients, mineral actives, and specialty ingredients. These products are supplied to sectors like pharmaceuticals, packaged foods, and dietary supplements.
Sudeep Pharma Share Price, IPO Listing, GMP Live: How Sudeep Pharma started
Sudeep Pharma began its operations in 1989 with one manufacturing unit focused on producing mineral excipients. From this small base, the company gradually expanded and now has subsidiaries in the United States and the Netherlands, along with a growing global distribution network.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Stock performance
Sudeep Pharma’s stock is trading in the positive zone, currently quoted at Rs 788.55 on the BSE, up Rs 54.60 or 7.44%, and at Rs 789.55 on the NSE, rising Rs 59 or 8.08%.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Stock performance at this hour
Sudeep Pharma shares continue to trade higher in the post-listing session. The stock is currently quoting at Rs 775.60 on the BSE, up Rs 41.65 or 5.67%, while on the NSE, it is trading at Rs 772.05, gaining Rs 42.05 or 5.76%.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Use of fresh issue funds
Out of the total fresh issue proceeds, Rs 76 crore will be spent on expanding capacity at the Nandesari manufacturing facility. The remaining amount will be used for general corporate needs, supporting operational flexibility and routine financial requirements.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Anchor book participation
Ahead of the public issue, the company raised Rs 268.5 crore from anchor investors.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Business model
Sudeep Pharma operates in the excipients and minerals space, supplying essential inputs used in pharma manufacturing. The company serves domestic and global clients and holds certifications that allow it to cater to regulated markets. Its products are linked to formulation stability, making them part of routine procurement cycles for customers.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Share performance post-listing
Sudeep Pharma shares continue to trade in the green. The stock is quoting at Rs 749.45 on the BSE, up Rs 15.50 or 2.11%, while on the NSE, it is trading at Rs 757.55, gaining Rs 27.55 or 3.77%.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Sudeep Pharma makes a strong debut on Dalal Street
Sudeep Pharma shares began trading on the stock exchanges with a strong listing premium today. The stock opened at Rs 733.95 on the BSE and Rs 730 on the NSE, compared to its issue price of Rs 593, translating to a listing gain of 23.8% on the BSE and 23.1% on the NSE.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Key financial metrics
For FY25, Sudeep Pharma reported revenue of Rs 501.9 crore, supported by strong margins across operating levels. The company posted a return on net worth of 27.88% and maintained PAT margins above 27%.
Sudeep Pharma Share Price, IPO Listing, GMP Live: International business
Sudeep Pharma serves over 1,100 customers spread across around 100 countries. The company’s largest export markets are in the USA, Europe, APAC and Africa regions. As of June 2025, the export sales accounted for 58.68% of the revenue from operations. The company has served over 1,100 global customers across pharma, food, nutrition, and FMCG sectors, including marquee names like Pfizer, Merck, and Danone.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Subscription trends
The IPO saw a strong demand, closing at 93.71 times overall subscription. Retail investors subscribed 15.65 times, non-institutional investors put in bids worth 116.72 times their quota, and the QIB category saw the heaviest response at 213.08 times.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Business operations
The company operate in two business verticals, pharmaceutical, food and nutrition, and speciality ingredients, comprising a portfolio of more than 100 products, including excipients, APIs, mineral actives and speciality ingredients and formulations with brands, such as Presscal, Pressmag, Lubriprez, A-comprez, Novelcap, Lipoboost and Cuvamix.
Sudeep Pharma Share Price, IPO Listing, GMP Live: IPO size and structure
Sudeep Pharma’s IPO combines a Rs 95 crore fresh issue with a much larger Rs 800 crore offer for sale, making it mostly an exit route for existing shareholders. Only a small portion of the proceeds will actually go to the company for business expansion, while the bulk represents promoter and investor stake dilution.
Pharma and nutraceutical ingredients face strict certification norms, where any non-compliance can immediately halt exports and disrupt business operations. With three manufacturing units and one R&D facility concentrated in Vadodara, Gujarat, any regional disruptions could potentially affect Sudeep Pharma's operational continuity.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Objectives of fresh issue
The offer comprises a fresh issue of Rs 95 crore and an offer for sale (OFS) of Rs 800 crore. The net proceeds will be used for capital expenditure towards the procurement of machinery for the production line located at Nandesari Facility I ( Rs 75.8 crore), and the remaining amount for general corporate purposes.
Sudeep Pharma Share Price, IPO Listing, GMP Live: Industry outlook
The global pharmaceutical excipients and speciality food ingredients markets together are projected to grow steadily, with excipients rising from $10.4 billion in 2024 to about $13 billion by 2029 (CAGR 4.7%), and speciality food ingredients expanding from $85 billion in 2024 to $118 billion by 2029 (CAGR 6.8%).
Sudeep Pharma Share Price, IPO Listing, GMP Live: About the company
Sudeep Pharma is a manufacturer of pharmaceutical excipients, food-grade minerals, and speciality nutrition ingredients serving over 100 countries. The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specialising in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. The company supplies more than 200 products to a diverse customer base across the pharma, food, and nutrition sectors